Hepatic resection is the only curative option for patients with hepatic metastases from colorectal cancer (CRC). Five-year survival rates after resection have reached almost 60% in recent series.1-3 This is largely attributed to more sophisticated preoperative imaging techniques, highly sensitive intraoperative ultrasonographic detection of small metastases, improved surgical techniques, and more effective systemic therapies.3,4
Bilchik AJ. Perioperative Carcinoembryonic Antigen Measurements to Predict Curability After Liver Resection for Colorectal Metastases—Invited Critique. Arch Surg. 2008;143(12):1158–1159. doi:10.1001/archsurg.143.12.1158
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: